180 Life Sciences
ATNF
#8662
Rank
$1.91 M
Marketcap
$2.03
Share price
-4.69%
Change (1 day)
87.96%
Change (1 year)

P/E ratio for 180 Life Sciences (ATNF)

P/E ratio as of July 2024 (TTM): -0.0848

According to 180 Life Sciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0847599. At the end of 2022 the company had a P/E ratio of -0.1753.

P/E ratio history for 180 Life Sciences from 2020 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.1753-96.77%
2021-5.4331.32%
2020-4.14

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-4.93 5,717.83%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.